{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:06:23Z","timestamp":1760781983605,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:00:00Z","timestamp":1678752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:00:00Z","timestamp":1678752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100017686","name":"Fujian Provincial Health Technology Project","doi-asserted-by":"publisher","award":["2021CXA011"],"award-info":[{"award-number":["2021CXA011"]}],"id":[{"id":"10.13039\/501100017686","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Natural Science Foundation of Fujian Province, China","award":["2022J02037"],"award-info":[{"award-number":["2022J02037"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173452"],"award-info":[{"award-number":["82173452"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Natural Science Foundation of Fujian Province","award":["2020J011014"],"award-info":[{"award-number":["2020J011014"]}]},{"name":"Excellent Young Scholars Cultivation Project of Fujian Medical University Union Hospital","award":["2022XH034"],"award-info":[{"award-number":["2022XH034"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstracts<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Preclinical studies suggest that glucocorticoids (GCs) promote the proliferation and development of colorectal cancer. Because GCs are broadly prescribed for treatment-related adverse events in patients with locally advanced rectal cancer (LARC) receiving neoadjuvant chemoradiotherapy (NCRT), it\u2019s essential to assess the effect of GCs on clinical outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>LARC cases treated with NCRT followed by surgery were assessed retrospectively. Evaluation of the relationship between GCs use (GCs vs. non-GCs) and neoadjuvant rectal (NAR) score (as a three-level categorical dependent variable) was performed using multivariable multinomial logistic regression (MLR). We also examined the relationship between the accumulated\u00a0dose of GCs and NAR using multivariate MLR. Survival analysis of disease-free survival (DFS) and overall survival (OS) was performed using the Kaplan\u2013Meier method. Multivariate Cox regression was used to assess confounding factors that could influence OS and DFS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>This retrospective cohort study included 790 patients with newly diagnosed non-metastatic LARC (T3-4\/N\u2009+\u2009M0) who received NCRT followed by surgery between January 2012 and April 2017. The end of the follow-up period was May 11, 2022. Among the 790 patients with LARC, 342 (43.2%) received GCs treatment and 448 (56.8%) did not during the NCRT-to-surgery period. GCs medication was significantly different between mid-NAR (8\u201316) and low-NAR (&lt;\u20098) (odds ratio [OR], 0.615; 95% CI, 0.420\u20130.901; <jats:italic>P<\/jats:italic>\u2009=\u20090.013), and the high-NAR (&gt;\u200916) and low-NAR (0.563; 0.352\u20130.900; 0.016). Patients exposed to GCs, had a decreased 5-year OS (GCs vs. non-GCs\u2009=\u200980.01% (95% CI, 75.87%\u201384.37%) vs. 85.30% (82.06%\u201388.67%), <jats:italic>P<\/jats:italic>\u2009=\u20090.023) and poorer 5-year DFS (73.99% (69.45%\u201378.82%) vs. 78.7% (75.14%\u201382.78%), <jats:italic>P<\/jats:italic>\u2009=\u20090.045). The accumulated dose of GCs was an independent risk factor for OS (hazard ratio [HR], 1.007 [1.001\u20131.014], 0.036) and DFS (1.010 [1.004\u20131.017], 0.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions and relevance<\/jats:title>\n                <jats:p>Our study revealed that GCs were associated with reduced efficacy of NCRT and worse clinical outcomes in patients with LARC during the NCRT-to-surgery period.\n<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-023-10592-0","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T09:03:29Z","timestamp":1678784609000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of glucocorticoids on the efficacy of neoadjuvant chemoradiotherapy and survival of patients with locally advanced rectal cancer: a retrospective study"],"prefix":"10.1186","volume":"23","author":[{"given":"Xiaoxue","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bangwei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuangbin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianyuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anchuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinghong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benhua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,14]]},"reference":[{"issue":"9349","key":"10592_CR1","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1016\/S0140-6736(02)11922-2","volume":"360","author":"HP Rutz","year":"2002","unstructured":"Rutz HP. Effects of corticosteroid use on treatment of solid tumours. Lancet. 2002;360(9349):1969\u201370.","journal-title":"Lancet"},{"issue":"11","key":"10592_CR2","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1002\/jcp.25408","volume":"231","author":"S Azher","year":"2016","unstructured":"Azher S, Azami O, Amato C, McCullough M, Celentano A, Cirillo N. The non-conventional effects of glucocorticoids in cancer. J Cell PhysioL. 2016;231(11):2368\u201373.","journal-title":"J Cell PhysioL"},{"issue":"1","key":"10592_CR3","doi-asserted-by":"publisher","first-page":"1673635","DOI":"10.1080\/2162402X.2019.1673635","volume":"9","author":"Y Ma","year":"2020","unstructured":"Ma Y, Yang H, Kroemer G. Endogenous and exogenous glucocorticoids abolish the efficacy of immune-dependent cancer therapies. Oncoimmunology. 2020;9(1):1673635.","journal-title":"Oncoimmunology"},{"key":"10592_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ejca.2020.09.020","volume":"141","author":"F Petrelli","year":"2020","unstructured":"Petrelli F, Bukovec R, Perego G, Luisa R, Luciani A, Zaniboni A, Ghidini A. Association of steroid use with survival in solid tumours. Eur J Cancer. 2020;141:105\u201314.","journal-title":"Eur J Cancer"},{"issue":"28","key":"10592_CR5","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1200\/JCO.2018.79.0006","volume":"36","author":"KC Arbour","year":"2018","unstructured":"Arbour KC, Mezquita L, Long N, Rizvi H, Auclin E, Ni A, Martinez-Bernal G, Ferrara R, Lai WV, Hendriks L, et al. Impact of baseline steroids on efficacy of programmed cell death-1 and programmed death-ligand 1 blockade in patients with non-small-cell lung cancer. J Clin Oncol. 2018;36(28):2872\u20138.","journal-title":"J Clin Oncol"},{"issue":"4","key":"10592_CR6","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1177\/1078155219872786","volume":"26","author":"EY Pan","year":"2020","unstructured":"Pan EY, Merl MY, Lin K. The impact of corticosteroid use during anti-PD1 treatment. J Oncol Pharm Pract. 2020;26(4):814\u201322.","journal-title":"J Oncol Pharm Pract"},{"issue":"1","key":"10592_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.canlet.2005.10.037","volume":"242","author":"C Zhang","year":"2006","unstructured":"Zhang C, Kolb A, Mattern J, Gassler N, Wenger T, Herzer K, Debatin KM, Buchler M, Friess H, Rittgen W, et al. Dexamethasone desensitizes hepatocellular and colorectal tumours toward cytotoxic therapy. Cancer Lett. 2006;242(1):104\u201311.","journal-title":"Cancer Lett"},{"issue":"2","key":"10592_CR8","doi-asserted-by":"publisher","first-page":"278","DOI":"10.4161\/cbt.6.2.3652","volume":"6","author":"C Zhang","year":"2007","unstructured":"Zhang C, Wenger T, Mattern J, Ilea S, Frey C, Gutwein P, Altevogt P, Bodenmuller W, Gassler N, Schnabel PA, et al. Clinical and mechanistic aspects of glucocorticoid-induced chemotherapy resistance in the majority of solid tumors. Cancer Biol Ther. 2007;6(2):278\u201387.","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"10592_CR9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.tem.2017.10.010","volume":"29","author":"J Vandewalle","year":"2018","unstructured":"Vandewalle J, Luypaert A, De Bosscher K, Libert C. Therapeutic mechanisms of glucocorticoids. Trends Endocrinol Metab. 2018;29(1):42\u201354.","journal-title":"Trends Endocrinol Metab"},{"key":"10592_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.steroids.2016.02.019","volume":"111","author":"KT Lin","year":"2016","unstructured":"Lin KT, Wang LH. New dimension of glucocorticoids in cancer treatment. Steroids. 2016;111:84\u20138.","journal-title":"Steroids"},{"issue":"3","key":"10592_CR11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1081\/CNV-200055960","volume":"23","author":"GR Morrow","year":"2005","unstructured":"Morrow GR, Shelke AR, Roscoe JA, Hickok JT, Mustian K. Management of cancer-related fatigue. Cancer Invest. 2005;23(3):229\u201339.","journal-title":"Cancer Invest"},{"issue":"12","key":"10592_CR12","first-page":"1321","volume":"21","author":"L Wang","year":"2018","unstructured":"Wang L, Wang J. Chinese consensus on diagnosis and treatment of radiation proctitis (2018). Zhonghua Wei Chang Wai Ke Za Zhi. 2018;21(12):1321\u201336.","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"issue":"7","key":"10592_CR13","doi-asserted-by":"publisher","first-page":"852","DOI":"10.6004\/jnccn.2018.0060","volume":"16","author":"AB Benson","year":"2018","unstructured":"Benson AB, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, et al. Anal carcinoma, version 2.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2018;16(7):852\u201371.","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"10592_CR14","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/SLA.0000000000000594","volume":"261","author":"MM Russell","year":"2015","unstructured":"Russell MM, Ganz PA, Lopa S, Yothers G, Ko CY, Arora A, Atkins JN, Bahary N, Soori GS, Robertson JM, et al. Comparative effectiveness of sphincter-sparing surgery versus abdominoperineal resection in rectal cancer: patient-reported outcomes in National Surgical Adjuvant Breast and Bowel Project randomized trial R-04. Ann Surg. 2015;261(1):144\u20138.","journal-title":"Ann Surg"},{"issue":"5","key":"10592_CR15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11888-015-0285-2","volume":"11","author":"TJ George","year":"2015","unstructured":"George TJ, Allegra CJ, Yothers G. Neoadjuvant Rectal (NAR) Score: a New Surrogate Endpoint in Rectal Cancer Clinical Trials. Curr Colorectal Cancer Rep. 2015;11(5):275\u201380.","journal-title":"Curr Colorectal Cancer Rep"},{"doi-asserted-by":"crossref","unstructured":"Ryan R, Gibbons D, Hyland JM, Treanor D, White A, Mulcahy HE, O\u2019Donoghue DP, Moriarty M, Fennelly D, Sheahan K. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology. 2005;47(2):141\u20136.","key":"10592_CR16","DOI":"10.1111\/j.1365-2559.2005.02176.x"},{"issue":"5","key":"10592_CR17","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1007\/s10787-017-0418-0","volume":"26","author":"L Chen","year":"2018","unstructured":"Chen L, Jondal M, Yakimchuk K. Regulatory effects of dexamethasone on NK and T cell immunity. Inflammopharmacology. 2018;26(5):1331\u20138.","journal-title":"Inflammopharmacology"},{"issue":"2","key":"10592_CR18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.bbi.2010.07.244","volume":"25","author":"K Krukowski","year":"2011","unstructured":"Krukowski K, Eddy J, Kosik KL, Konley T, Janusek LW, Mathews HL. Glucocorticoid dysregulation of natural killer cell function through epigenetic modification. Brain Behav Immun. 2011;25(2):239\u201349.","journal-title":"Brain Behav Immun"},{"issue":"17","key":"10592_CR19","doi-asserted-by":"publisher","first-page":"9573","DOI":"10.1073\/pnas.160099797","volume":"97","author":"M Bianchi","year":"2000","unstructured":"Bianchi M, Meng C, Ivashkiv LB. Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids. Proc Natl Acad Sci U S A. 2000;97(17):9573\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10592_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nri1256","volume":"4","author":"H Hackstein","year":"2004","unstructured":"Hackstein H, Thomson AW. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol. 2004;4(1):24\u201334.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10592_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.yexcr.2017.09.036","volume":"361","author":"M Wang","year":"2017","unstructured":"Wang M, Chen B, Sun XX, Zhao XD, Zhao YY, Sun L, Xu CG, Shen B, Su ZL, Xu WR, et al. Gastric cancer tissue-derived mesenchymal stem cells impact peripheral blood mononuclear cells via disruption of Treg\/Th17 balance to promote gastric cancer progression. Exp Cell ReS. 2017;361(1):19\u201329.","journal-title":"Exp Cell ReS"},{"issue":"3","key":"10592_CR22","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/eji.200324506","volume":"34","author":"X Chen","year":"2004","unstructured":"Chen X, Murakami T, Oppenheim JJ, Howard O. Differential response of murine CD4+CD25+ and CD4+CD25- T cells to dexamethasone-induced cell death. Eur J Immunol. 2004;34(3):859\u201369.","journal-title":"Eur J Immunol"},{"issue":"9","key":"10592_CR23","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1038\/s41591-019-0566-4","volume":"25","author":"H Yang","year":"2019","unstructured":"Yang H, Xia L, Chen J, Zhang S, Martin V, Li Q, Lin S, Chen J, Calmette J, Lu M, et al. Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity. Nat MeD. 2019;25(9):1428\u201341.","journal-title":"Nat MeD"},{"issue":"2","key":"10592_CR24","doi-asserted-by":"publisher","first-page":"e001361","DOI":"10.1136\/jitc-2020-001361","volume":"8","author":"A Cortellini","year":"2020","unstructured":"Cortellini A, Tucci M, Adamo V, Stucci LS, Russo A, Tanda ET, Spagnolo F, Rastelli F, Bisonni R, Santini D, et al. Integrated analysis of concomitant medications and oncological outcomes from PD-1\/PD-L1 checkpoint inhibitors in clinical practice. J Immunother Cancer. 2020;8(2):e001361.","journal-title":"J Immunother Cancer"},{"issue":"Suppl 4","key":"10592_CR25","doi-asserted-by":"publisher","first-page":"S364","DOI":"10.21037\/tlcr.2019.06.06","volume":"8","author":"M Jove","year":"2019","unstructured":"Jove M, Vilarino N, Nadal E. Impact of baseline steroids on efficacy of programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) blockade in patients with advanced non-small cell lung cancer. Transl Lung Cancer Res. 2019;8(Suppl 4):S364\u20138.","journal-title":"Transl Lung Cancer Res"},{"issue":"4","key":"10592_CR26","doi-asserted-by":"publisher","first-page":"529","DOI":"10.4161\/onci.19459","volume":"1","author":"D Sidler","year":"2012","unstructured":"Sidler D, Renzulli P, Schnoz C, Berger B, Schneider-Jakob S, Fluck C, Inderbitzin D, Corazza N, Candinas D, Brunner T. Colon cancer cells produce immunoregulatory glucocorticoids. Oncoimmunology. 2012;1(4):529\u201330.","journal-title":"Oncoimmunology"},{"issue":"24","key":"10592_CR27","doi-asserted-by":"publisher","first-page":"e151815","DOI":"10.1172\/jci.insight.151815","volume":"6","author":"S Tang","year":"2021","unstructured":"Tang S, Zhang Z, Oakley RH, Li W, He W, Xu X, Ji M, Xu Q, Chen L, Wellman AS, et al. Intestinal epithelial glucocorticoid receptor promotes chronic inflammation-associated colorectal cancer. JCI Insight. 2021;6(24):e151815.","journal-title":"JCI Insight"},{"issue":"4","key":"10592_CR28","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3390\/cancers12040945","volume":"12","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Dong L, Jia A, Chen X, Yang Q, Wang Y, Wang Y, Liu R, Cao Y, He Y, et al. Glucocorticoids Promote the Onset of Acute Experimental Colitis and Cancer by Upregulating mTOR Signaling in Intestinal Epithelial Cells. Cancers (Basel). 2020;12(4):945.","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10592_CR29","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/apt.12667","volume":"39","author":"EB Ostenfeld","year":"2014","unstructured":"Ostenfeld EB, Erichsen R, Thorlacius-Ussing O, Riis AH, Sorensen HT. Pre-admission use of glucocorticoids and 30-day mortality following colorectal cancer surgery: a population-based Danish cohort study. Aliment Pharmacol Ther. 2014;39(8):843\u201353.","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10592_CR30","doi-asserted-by":"publisher","first-page":"e8045","DOI":"10.1136\/bmjopen-2015-008045","volume":"5","author":"EB Ostenfeld","year":"2015","unstructured":"Ostenfeld EB, Erichsen R, Baron JA, Thorlacius-Ussing O, Iversen LH, Riis AH, Sorensen HT. Preadmission glucocorticoid use and anastomotic leakage after colon and rectal cancer resections: a Danish cohort study. BMJ Open. 2015;5(9):e8045.","journal-title":"BMJ Open"},{"issue":"Suppl 1","key":"10592_CR31","doi-asserted-by":"publisher","first-page":"i68","DOI":"10.1093\/bja\/aet577","volume":"113","author":"PP Singh","year":"2014","unstructured":"Singh PP, Lemanu DP, Taylor MH, Hill AG. Association between preoperative glucocorticoids and long-term survival and cancer recurrence after colectomy: follow-up analysis of a previous randomized controlled trial. Br J Anaesth. 2014;113(Suppl 1):i68\u201373.","journal-title":"Br J Anaesth"},{"issue":"1","key":"10592_CR32","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12885-019-5299-8","volume":"19","author":"B Li","year":"2019","unstructured":"Li B, Wang Y, Yin L, Huang G, Xu Y, Su J, Ma L, Lu J. Glucocorticoids promote the development of azoxymethane and dextran sulfate sodium-induced colorectal carcinoma in mice. BMC Cancer. 2019;19(1):94.","journal-title":"BMC Cancer"},{"issue":"1","key":"10592_CR33","doi-asserted-by":"publisher","first-page":"11257","DOI":"10.1038\/s41598-019-47696-2","volume":"9","author":"D Tian","year":"2019","unstructured":"Tian D, Tian M, Han G, Li JL. Increased glucocorticoid receptor activity and proliferation in metastatic colon cancer. Sci Rep. 2019;9(1):11257.","journal-title":"Sci Rep"},{"key":"10592_CR34","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1471-2407-14-46","volume":"14","author":"J Vonlanthen","year":"2014","unstructured":"Vonlanthen J, Okoniewski MJ, Menigatti M, Cattaneo E, Pellegrini-Ochsner D, Haider R, Jiricny J, Staiano T, Buffoli F, Marra G. A comprehensive look at transcription factor gene expression changes in colorectal adenomas. BMC Cancer. 2014;14:46.","journal-title":"BMC Cancer"},{"issue":"9","key":"10592_CR35","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1023\/A:1025578527978","volume":"48","author":"S Theocharis","year":"2003","unstructured":"Theocharis S, Kouraklis G, Margeli A, Agapitos E, Ninos S, Karatzas G, Koutselinis A. Glucocorticoid receptor (GR) immunohistochemical expression is correlated with cell cycle-related molecules in human colon cancer. Dig Dis Sci. 2003;48(9):1745\u201350.","journal-title":"Dig Dis Sci"},{"issue":"23","key":"10592_CR36","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1200\/JCO.2010.33.1595","volume":"29","author":"V Valentini","year":"2011","unstructured":"Valentini V, van Stiphout RG, Lammering G, Gambacorta MA, Barba MC, Bebenek M, Bonnetain F, Bosset JF, Bujko K, Cionini L, et al. Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. J Clin Oncol. 2011;29(23):3163\u201372.","journal-title":"J Clin Oncol"},{"issue":"7","key":"10592_CR37","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1093\/annonc\/mdy143","volume":"29","author":"E Fokas","year":"2018","unstructured":"Fokas E, Fietkau R, Hartmann A, Hohenberger W, Grutzmann R, Ghadimi M, Liersch T, Strobel P, Grabenbauer GG, Graeven U, et al. Neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO\/ARO\/AIO-04 randomized phase III trial. Ann Oncol. 2018;29(7):1521\u20137.","journal-title":"Ann Oncol"},{"doi-asserted-by":"crossref","unstructured":"Rosello S, Frasson M, Garcia-Granero E, Roda D, Jorda E, Navarro S, Campos S, Esclapez P, Garcia-Botello S, Flor B, et al. Integrating Downstaging in the Risk Assessment of Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy: Validation of Valentini\u2019s Nomograms and the Neoadjuvant Rectal Score. Clin Colorectal Cancer. 2018;17(2):104\u201312.","key":"10592_CR38","DOI":"10.1016\/j.clcc.2017.10.014"},{"issue":"1","key":"10592_CR39","doi-asserted-by":"publisher","first-page":"e215445","DOI":"10.1001\/jamaoncol.2021.5445","volume":"8","author":"E Fokas","year":"2022","unstructured":"Fokas E, Schlenska-Lange A, Polat B, Klautke G, Grabenbauer GG, Fietkau R, Kuhnt T, Staib L, Brunner T, Grosu AL, et al. Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO\/ARO\/AIO-12 Randomized Clinical Trial. JAMA ONCOL. 2022;8(1):e215445.","journal-title":"JAMA ONCOL"},{"key":"10592_CR40","first-page":"D12529","volume":"1","author":"TA Lawrie","year":"2018","unstructured":"Lawrie TA, Green JT, Beresford M, Wedlake L, Burden S, Davidson SE, Lal S, Henson CC, Andreyev H. Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers. Cochrane Database Syst Rev. 2018;1:D12529.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10592_CR41","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3109\/02841869409098437","volume":"33","author":"O Dahl","year":"1994","unstructured":"Dahl O, Horn A, Mella O. Do acute side-effects during radiotherapy predict tumour response in rectal carcinoma? Acta Oncol. 1994;33(4):409\u201313.","journal-title":"Acta Oncol"},{"issue":"1","key":"10592_CR42","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s00066-009-2037-1","volume":"186","author":"HA Wolff","year":"2010","unstructured":"Wolff HA, Gaedcke J, Jung K, Hermann RM, Rothe H, Schirmer M, Liersch T, Herrmann M, Hennies S, Rave-Frank M, et al. High-grade acute organ toxicity during preoperative radiochemotherapy as positive predictor for complete histopathologic tumor regression in multimodal treatment of locally advanced rectal cancer. Strahlenther Onkol. 2010;186(1):30\u20135.","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"10592_CR43","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.radonc.2013.05.009","volume":"108","author":"HA Wolff","year":"2013","unstructured":"Wolff HA, Conradi LC, Beissbarth T, Leha A, Hohenberger W, Merkel S, Fietkau R, Raab HR, Tschmelitsch J, Hess CF, et al. Gender affects acute organ toxicity during radiochemotherapy for rectal cancer: long-term results of the German CAO\/ARO\/AIO-94 phase III trial. Radiother Oncol. 2013;108(1):48\u201354.","journal-title":"Radiother Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-023-10592-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-023-10592-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-023-10592-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T20:34:19Z","timestamp":1679862859000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-023-10592-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,14]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["10592"],"URL":"https:\/\/doi.org\/10.1186\/s12885-023-10592-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2023,3,14]]},"assertion":[{"value":"15 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional review board of Fujian Medical University Union Hospital. All methods were performed in accordance with the relevant guidelines and regulations (Declaration of Helsinki). The need for informed consent was waived by the ethics Institutional Review Board of Fujian Medical University Union Hospital, because of the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"238"}}